Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia-Reference-Cited by-同舟云学术

Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia

Published:2020-01 Issue: Volume:185 Page:111838
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Lupia Antonio^ORCID,Mimmi Selena,Iaccino Enrico,Maisano Domenico,Moraca Federica,Talarico Carmine,Vecchio Eleonora,Fiume Giuseppe,Ortuso Francesco^ORCID,Scala Giuseppe,Quinto Ileana,Alcaro Stefano^ORCID

Funder

NCR

Fondazione Italiana per la Ricerca sul Cancro

EU project

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference59 articles.

1. Molecular basis of CLL;Pekarsky;Semin. Cancer Biol.,2010

2. The chronic lymphocytic leukaemia market;Esencay;Nat. Rev. Drug Discov.,2015

3. The expression of inhibitor of bruton’s tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis;Albano;Cell Death Dis.,2018

4. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications;Campo;Blood,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TDC-2: Multimodal Foundation for Therapeutic Science;2024-06-14

2. Synthesis, biological evaluation and metadynamics simulations of novel N-methyl β-sheet breaker peptides as inhibitors of Alzheimer's β-amyloid fibrillogenesis;RSC Medicinal Chemistry;2024

3. Interaction between the antioxidant compound safranal and α-chymotrypsin in spectroscopic fields and molecular modeling approaches;Journal of Biomolecular Structure and Dynamics;2023-11-15

4. In silico nanotoxicology: The computational biology state of art for nanomaterial safety assessments;Materials & Design;2023-11

5. Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype;Cells;2023-04-03